On January 10, the country's first indolent lymphoma clinic was officially opened in the Tuanbo Campus of the Blood Disease Hospital of the Chinese Academy of Medical Sciences. The clinic aims to provide standardized, standardized and high-quality diagnosis and follow-up for patients with indolent lymphoma, and provide a medical channel of "special disease, special diagnosis and special treatment" to help the high-quality management of indolent lymphoma.
Caption: Professor Qiu Lugui, Director of the Lymphoma Diagnosis and Treatment Center of the Blood Disease Hospital of the Chinese Academy of Medical Sciences, visited the clinic.
Specialized diseases, specialized diagnosis, and specialized treatment.
Indolent lymphoma is a group of non-Hodgkin lymphoma with relatively slow clinical progression, complex classification, difficult diagnosis, high rate, and inability, patients usually need regular follow-up, and repeatedly running between hospitals often makes them physically and mentally exhausted, which is why the establishment of a specialist outpatient clinic. The clinic is dedicated to the treatment of specific diseases, and is open every Wednesday morning, providing patients with indolent lymphoma with high-quality, long-term disease control, so that patients can not only live longer, but also live well. From diagnosis to diagnosis, from follow-up to management, the specialist clinic can provide patients with diagnosis and treatment services from the whole cycle, and also make the communication between doctors and patients more convenient.
The indolent lymphoma clinic focuses on patients with indolent lymphoma, and forms a referral alliance with provincial and municipal hospitals across the country to simplify the medical treatment process for patients with indolent lymphoma and achieve the effect of homogeneous diagnosis and treatment across the country. The successful opening of the indolent lymphoma clinic will help promote the standardization and homogeneity of diagnosis and treatment of indolent lymphoma, provide convenient medical channels for patients with indolent lymphoma, and is of great significance to improve the overall development of indolent lymphoma.
Let lymphoma patients live longer, live better.
For patients with indolent lymphoma, there are three thirds. One-third of patients with **indications need to be done immediately**, one-third of patients need to be observed for a period of time before undergoing **, and one-third of patients do not need ** for life**.
This means that the disease stays with the patient for the rest of their lives.
As the first indolent lymphoma clinic in China, it will formulate diagnosis and treatment plans based on the own conditions of patients with different types of indolent lymphoma, and strive to maximize the benefits of patients. It is hoped that based on the Beijing-Tianjin-Hebei region, it can also radiate to the whole country, so that more patients can receive systematic and standardized ** in the specialist outpatient clinic. At the same time, it is also hoped that this diagnosis and treatment model will be extended to the whole country.